With respect to lung carcinomas, the expression of ADAM28 was also elevated, suggesting that it may be a better serological and immunohistochemical marker for non-small-cell lung cancers (NSCLC) [19]. This evidence concerns the gene ADAM28 and non-small cell lung carcinoma.